Hematocrit
High hematocrit levels rare for adults receiving gender-confirming testosterone therapy
Fewer than 1% of adults receiving exogenous testosterone for gender-confirming hormone therapy have a hematocrit level above the norm of 54%, according to data published in The Journal of Clinical Endocrinology & Metabolism.
VIDEO: White blood cell count correlates with thrombotic risk in polycythemia vera
In this video, Aaron T. Gerds, MD, MS, discusses critical takeaways from the REVEAL study presented at ASH Annual Meeting and Exposition.
Rusfertide reduces hematocrit without phlebotomy in polycythemia vera
Induction therapy with twice-weekly rusfertide helped patients with polycythemia vera achieve target hematocrit below 45% without phlebotomy, according to a study presented at ASH Annual Meeting and Exposition.
Race may influence biochemical responses to testosterone therapy
A small cohort of white and South Asian men experienced different biochemical responses to treatment with testosterone replacement therapy when analyzed according to race, according to findings published in Clinical Endocrinology.